 Positron-Emission Tomography
"Positron-Emission Tomography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
| Descriptor ID |
D049268
|
| MeSH Number(s) |
E01.370.350.350.800.700 E01.370.350.600.350.800.399 E01.370.350.710.800.399 E01.370.350.825.800.399 E01.370.384.730.800.399
|
| Concept/Terms |
Positron-Emission Tomography- Positron-Emission Tomography
- Positron Emission Tomography
- PET Scan
- PET Scans
- Scan, PET
- Scans, PET
- Tomography, Positron-Emission
- Tomography, Positron Emission
|
Below are MeSH descriptors whose meaning is more general than "Positron-Emission Tomography".
Below are MeSH descriptors whose meaning is more specific than "Positron-Emission Tomography".
This graph shows the total number of publications written about "Positron-Emission Tomography" by people in UAMS Profiles by year, and whether "Positron-Emission Tomography" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 3 | 5 | | 2023 | 2 | 5 | 7 | | 2022 | 0 | 6 | 6 | | 2021 | 0 | 3 | 3 | | 2020 | 2 | 3 | 5 | | 2019 | 4 | 2 | 6 | | 2018 | 2 | 2 | 4 | | 2017 | 6 | 3 | 9 | | 2016 | 4 | 8 | 12 | | 2015 | 3 | 4 | 7 | | 2014 | 3 | 9 | 12 | | 2013 | 9 | 2 | 11 | | 2012 | 5 | 7 | 12 | | 2011 | 4 | 3 | 7 | | 2010 | 5 | 3 | 8 | | 2009 | 6 | 5 | 11 | | 2008 | 1 | 8 | 9 | | 2007 | 1 | 4 | 5 | | 2006 | 4 | 3 | 7 | | 2005 | 4 | 3 | 7 | | 2004 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles over the past ten years.
-
Baldelomar EJ, Zhang H, Thorek D, Charlton JR, Walker PD, Wilson LD, Emoto KC, Clavijo Jordan V, Reichert DE, Shoghi K, Bennett KM. Development and Use of Human Recombinant 64Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography. ACS Appl Bio Mater. 2024 Oct 21; 7(10):6392-6397.
-
Figdore DJ, Griswold M, Bornhorst JA, Graff-Radford J, Ramanan VK, Vemuri P, Lowe VJ, Knopman DS, Jack CR, Petersen RC, Algeciras-Schimnich A. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement. 2024 Sep; 20(9):6506-6516.
-
Younes K, Smith V, Johns E, Carlson ML, Winer J, He Z, Henderson VW, Greicius MD, Young CB, Mormino EC. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer's disease. Brain Behav Immun. 2024 Jul; 119:807-817.
-
Palot Manzil FF, Eichhorn J, Kaur H. Systemic and Neurosarcoidosis With Rare Involvement of the Extremities' Peripheral Nerves. Clin Nucl Med. 2024 Jun 01; 49(6):e292-e294.
-
Young CB, Smith V, Karjadi C, Grogan SM, Ang TFA, Insel PS, Henderson VW, Sumner M, Poston KL, Au R, Mormino EC. Speech patterns during memory recall relates to early tau burden across adulthood. Alzheimers Dement. 2024 04; 20(4):2552-2563.
-
Fettahoglu A, Zhao M, Khalighi M, Vossler H, Jovin M, Davidzon G, Zeineh M, Boada F, Mormino E, Henderson VW, Moseley M, Chen KT, Zaharchuk G. Early-Frame [18F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [15O]Water Gold Standard. J Nucl Med. 2024 Feb 01; 65(2):306-312.
-
Shashi KK, Weldon CB, Voss SD. Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatr Radiol. 2024 05; 54(5):671-683.
-
Perlow HK, Nalin AP, Handley D, Gokun Y, Blakaj DM, Beyer SJ, Thomas EM, Raval RR, Boulter D, Kleefisch C, Bovi J, Chen WC, Braunstein SE, Raleigh DR, Knisely JPS, Ivanidze J, Palmer JD. A Prospective Registry Study of 68Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118(4):979-985.
-
Sunderland JJ, Graves SA, York DM, Mundt CA, Bartel TB. Response to "Critique and Discussion of 'Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose'". J Nucl Med. 2023 10; 64(10):1664-1667.
-
Jacobsen MC, Maheshwari E, Klopp AH, Venkatesan AM. Image-Guided Radiotherapy for Gynecologic Malignancies: What the Radiologist Needs to Know. Radiol Clin North Am. 2023 Jul; 61(4):725-747.
-
Sunderland JJ, Graves SA, York DM, Mundt CA, Bartel TB. Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose. J Nucl Med. 2023 07; 64(7):1095-1101.
-
Oh C, Bishop MW, Cho SY, Im HJ, Shulkin BL. 18F-FDG PET/CT in the Management of Osteosarcoma. J Nucl Med. 2023 06; 64(6):842-851.
-
Alkharisi B, Dostzada K, Kaur H, Kumar M, Wei JY, Azhar G. The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias. Am J Case Rep. 2023 Apr 05; 24:e938344.
-
Yamamoto A, Nagao M, Inai K, Shinkawa T. Coronary microvascular dysfunction detected by 13N-ammonia positron emission tomography in a patient with repaired aortic coarctation. J Nucl Cardiol. 2023 12; 30(6):2819-2822.
-
Stack BC, Duan F, Romanoff J, Sicks JD, Subramaniam RM, Lowe VJ. Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685. Clin Nucl Med. 2023 Feb 01; 48(2):126-131.
-
Ahrens SM, Arredondo KH, Bagic AI, Bai S, Chapman KE, Ciliberto MA, Clarke DF, Eisner M, Fountain NB, Gavvala JR, Perry MS, Rossi KC, Wong-Kisiel LC, Herman ST, Ostendorf AP. Epilepsy center characteristics and geographic region influence presurgical testing in the United States. Epilepsia. 2023 01; 64(1):127-138.
-
Baltz AP, Siegel ER, Kamal AH, Siegel R, Kozlik MM, Crist STS, Makhoul I. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data. JCO Oncol Pract. 2023 02; 19(2):e274-e285.
-
Dienel GA, Gillinder L, McGonigal A, Borges K. Potential new roles for glycogen in epilepsy. Epilepsia. 2023 01; 64(1):29-53.
-
Heidemeier A, Schloetelburg W, Thurner A, Metz C, Heidemeier H, Rasche L, Martin Kortuem K, Boeckle D, Weiland E, Benkert T, Nickel D, Werner R, Buck AK, Bley TA. Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by 18F-FDG and 11C-methionine PET/CT. Eur J Radiol. 2022 Oct; 155:110493.
-
Rasche L, Schinke C, Maura F, Bauer MA, Ashby C, Deshpande S, Poos AM, Zangari M, Thanendrarajan S, Davies FE, Walker BA, Barlogie B, Landgren O, Morgan GJ, van Rhee F, Weinhold N. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states. Nat Commun. 2022 08 03; 13(1):4517.
-
B?ckle D, Tabares P, Zhou X, Schimanski S, Steinhardt MJ, Bittrich M, Seebacher E, Ulbrich M, Wilnit A, Metz C, Heidemeier A, Bley T, Werner R, Buck A, Einsele H, Kort?m KM, Beilhack A, Rasche L. Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma. Br J Haematol. 2022 08; 198(3):515-522.
-
Perlow HK, Siedow M, Gokun Y, McElroy J, Matsui J, Zoller W, Beyer S, Arnett A, Blakaj D, Boulter D, Fritz J, Miller E, Raval R, Kleefisch C, Bovi J, Palmer JD. 68Ga-DOTATATE PET-Based Radiation Contouring Creates More Precise Radiation Volumes for Patients With Meningioma. Int J Radiat Oncol Biol Phys. 2022 07 15; 113(4):859-865.
-
Mathai SV, Patel S, Jorde UP, Rochlani Y. Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis. Methodist Debakey Cardiovasc J. 2022; 18(2):78-93.
-
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status. Haematologica. 2021 12 01; 106(12):3215-3218.
-
Rutherford M, Mun SK, Levine B, Bennett W, Smith K, Farmer P, Jarosz Q, Wagner U, Freyman J, Blake G, Tarbox L, Farahani K, Prior F. A DICOM dataset for evaluation of medical image de-identification. Sci Data. 2021 07 16; 8(1):183.
-
Zhang X, Talpos J, Berridge MS, Apana SM, Slikker W, Wang C, Paule MG. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates. Neurotoxicol Teratol. 2021 Sep-Oct; 87:107017.
-
Wang ZT, Shen XN, Ma YH, Ou YN, Dong PQ, Tan PL, Yu PJ. Associations of the Rate of Change in Geriatric Depression Scale with Amyloid and Cerebral Glucose Metabolism in Cognitively Normal Older Adults: A Longitudinal Study. J Affect Disord. 2021 02 01; 280(Pt A):77-84.
-
Sawyer DM, Sawyer TW, Eshghi N, Hsu C, Hamilton RJ, Garland LL, Kuo PH. Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in 18F-FDG Uptake of the Brain After Prophylactic Cranial Irradiation. J Nucl Med Technol. 2021 Mar; 49(1):34-38.
-
Kuruva M, Moncayo VM, Peterson RB. PET and SPECT Imaging of Epilepsy: Technical Considerations, Pathologies, and Pitfalls. Semin Ultrasound CT MR. 2020 Dec; 41(6):551-561.
-
Ostwani W, Hanna C, Brice AE, Wymer DC. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential 18F-FDG PET Examinations. J Nucl Med Technol. 2020 Dec; 48(4):378-380.
-
Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. N Engl J Med. 2020 05 14; 382(20):1926-1932.
-
Li A, Sanchez-Petitto G, Tkaczuk KHR, Nageshwar M, Singh Z, Kocoglu M. An Unusual Cause of a Pathological Vertebral Fracture: Solitary Plasmacytoma. Am J Med Sci. 2020 08; 360(2):206-207.
-
Xin Y, Yue X, Li H, Li Z, Cai H, Choudhary AK, Zhang S, Chugani DC, Langhans SA. PET imaging of medulloblastoma with an 18F-labeled tryptophan analogue in a transgenic mouse model. Sci Rep. 2020 03 02; 10(1):3800.
-
Du K, Chitneni SK, Suzuki A, Wang Y, Henao R, Hyun J, Premont RT, Naggie S, Moylan CA, Bashir MR, Abdelmalek MF, Diehl AM. Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. Cell Mol Gastroenterol Hepatol. 2020; 10(1):1-21.
-
Armstrong LE, Kavouras SA. Thirst and Drinking Paradigms: Evolution from Single Factor Effects to Brainwide Dynamic Networks. Nutrients. 2019 Nov 22; 11(12).
-
Karivedu V, Jain AL, Eluvathingal TJ, Sidana A. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma. Curr Urol Rep. 2019 Aug 29; 20(10):56.
-
Davenport MS, Montgomery JS, Kunju LP, Siddiqui J, Shankar PR, Rajendiran T, Shao X, Lee E, Denton B, Barnett C, Piert M. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies. J Nucl Med. 2020 03; 61(3):337-343.
-
Barnett CL, Davenport MS, Montgomery JS, Kunju LP, Denton BT, Piert M. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis. J Nucl Med. 2019 12; 60(12):1705-1712.
-
Osmany S, Zaheer S, Bartel TB, Johnston M, Peh WM, Barmaky S, Jadvar H. Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers. AJR Am J Roentgenol. 2019 08; 213(2):286-299.
-
Cao XX, Niu N, Sun J, Cai H, Wang FD, Wang YN, Duan MH, Zhou DB, Li J. Clinical and positron emission tomography responses to long-term high-dose interferon-a treatment among patients with Erdheim-Chester disease. Orphanet J Rare Dis. 2019 01 10; 14(1):11.
-
Rasche L, Alapat D, Kumar M, Gershner G, McDonald J, Wardell CP, Samant R, Van Hemert R, Epstein J, Williams AF, Thanendrarajan S, Schinke C, Bauer M, Ashby C, Tytarenko RG, van Rhee F, Walker BA, Zangari M, Barlogie B, Davies FE, Morgan GJ, Weinhold N. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma. Leukemia. 2019 07; 33(7):1713-1722.
-
Kaiser RH, Treadway MT, Wooten DW, Kumar P, Goer F, Murray L, Beltzer M, Pechtel P, Whitton A, Cohen AL, Alpert NM, El Fakhri G, Normandin MD, Pizzagalli DA. Frontostriatal and Dopamine Markers of Individual Differences in Reinforcement Learning: A Multi-modal Investigation. Cereb Cortex. 2018 12 01; 28(12):4281-4290.
-
Lundeen TF, Seibyl JP, Covington MF, Eshghi N, Kuo PH. Signs and Artifacts in Amyloid PET. Radiographics. 2018 Nov-Dec; 38(7):2123-2133.
-
Kumar A, Juh?sz C, Luat A, Govil-Dalela T, Behen ME, Hicks MA, Chugani HT. Evolution of Brain Glucose Metabolic Abnormalities in Children With Epilepsy and SCN1A Gene Variants. J Child Neurol. 2018 11; 33(13):832-836.
-
Dienel GA, Behar KL, Rothman DL. Cellular Origin of [18F]FDG-PET Imaging Signals During Ceftriaxone-Stimulated Glutamate Uptake: Astrocytes and Neurons. Neuroscientist. 2018 08; 24(4):316-328.
-
Kim JA, Jeong JW, Behen ME, Pilli VK, Luat A, Chugani HT, Juh?sz C. Metabolic correlates of cognitive function in children with unilateral Sturge-Weber syndrome: Evidence for regional functional reorganization and crowding. Hum Brain Mapp. 2018 04; 39(4):1596-1606.
-
Tuominen L, Miettunen J, Cannon DM, Drevets WC, Frokjaer VG, Hirvonen J, Ichise M, Jensen PS, Keltikangas-J?rvinen L, Klaver JM, Knudsen GM, Takano A, Suhara T, Hietala J. Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females. Int J Neuropsychopharmacol. 2017 12 01; 20(12):963-970.
-
Bagla S, Cukovic D, Asano E, Sood S, Luat A, Chugani HT, Chugani DC, Dombkowski AA. A distinct microRNA expression profile is associated with a[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex. Neurobiol Dis. 2018 Jan; 109(Pt A):76-87.
-
Joshi KP, Kaphle U, Steliga MA, Bartter T, Priyambada P, Jiwani S. Inflammatory Myofibroblastic Tumor of the Lung. A Rare Primary Lung Cancer. Am J Respir Crit Care Med. 2017 Oct 01; 196(7):923-924.
-
Naylor JE, Hiranita T, Matazel KS, Zhang X, Paule MG, Goodwin AK. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride. Drug Alcohol Depend. 2017 10 01; 179:254-259.
-
Palot Manzil FF, Baldwin J, Bag AK. Pediatric Skeletal Scintigraphy: What a General Radiologist Needs to Know. Curr Probl Diagn Radiol. 2018 Jul - Aug; 47(4):270-281.
-
Chondronikola M, Porter C, Malagaris I, Nella AA, Sidossis LS. Brown adipose tissue is associated with systemic concentrations of peptides secreted from the gastrointestinal system and involved in appetite regulation. Eur J Endocrinol. 2017 Jul; 177(1):33-40.
-
Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, Thanendrarajan S, Schinke C, Samant R, Yaccoby S, Walker BA, Epstein J, Zangari M, van Rhee F, Meissner T, Goldschmidt H, Hemminki K, Houlston R, Barlogie B, Davies FE, Morgan GJ, Weinhold N. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017 07 06; 130(1):30-34.
-
Joehlin-Price AS, Hardesty DA, Arnold CA, Kirschner LS, Prevedello DM, Lehman NL. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing's disease. Diagn Pathol. 2017 Apr 18; 12(1):34.
-
McClinton C, Niroumand M, Sood S, Shah V, Hill J, Dusing RW, Shen X. Patterns of lymph node positivity on 11C-acetate PET imaging in correlation to the RTOG pelvic radiation field for prostate cancer. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):325-331.
-
Kalantari F, Wang J. Attenuation correction in 4D-PET using a single-phase attenuation map and rigidity-adaptive deformable registration. Med Phys. 2017 Feb; 44(2):522-532.
-
Mohan M, Fogel B, Eluvathingal T, Schinke C, Kothari A. Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma. Transpl Infect Dis. 2016 Dec; 18(6):939-941.
-
Penthala NR, Janganati V, Alpe TL, Apana SM, Berridge MS, Crooks PA, Borrelli MJ. N-[11CH3]Dimethylaminoparthenolide (DMAPT) uptake into orthotopic 9LSF glioblastoma tumors in the rat. Bioorg Med Chem Lett. 2016 12 15; 26(24):5883-5886.
-
Kamel MK, Rahouma M, Ghaly G, Nasar A, Port JL, Stiles BM, Nguyen AB, Altorki NK, Lee PC. Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017 Jan; 103(1):281-286.
-
Subramaniam RM, Shields AF, Sachedina A, Hanna L, Duan F, Siegel BA, Hillner BE. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry. Oncologist. 2016 09; 21(9):1079-84.
-
Zhang X, Liu S, Newport GD, Paule MG, Callicott R, Thompson J, Liu F, Patterson TA, Berridge MS, Apana SM, Brown CC, Maisha MP, Hanig JP, Slikker W, Wang C. In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography. Anesthesiology. 2016 07; 125(1):133-46.
-
Zhang X, Newport GD, Callicott R, Liu S, Thompson J, Berridge MS, Apana SM, Slikker W, Wang C, Paule MG. MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates. Neurotoxicol Teratol. 2016 Jul-Aug; 56:68-74.
-
Spector ME, Chinn SB, Bellile E, Gallagher KK, Kang SY, Moyer JS, Prince ME, Wolf GT, Bradford CR, McHugh JB, Carey TE, Worden FP, Eisbruch A, Ibrahim M, Chepeha DB. Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):313-8.
-
Guidry C, Fricke RG, Ram R, Pandey T, Jambhekar K. Imaging of Sarcoidosis: A Contemporary Review. Radiol Clin North Am. 2016 May; 54(3):519-34.
-
Lieber B, Han B, Allen J, Fatterpekar G, Agarwal N, Kazemi N, Zagzag D. Utility of positron emission tomography in schwannomatosis. J Clin Neurosci. 2016 Aug; 30:138-140.
-
Kuruva M, Shah HR, Dunn AL, McDonald JE. 111In-Pentetreotide Imaging in Diffuse Idiopathic Neuroendocrine Hyperplasia of the Lung. Clin Nucl Med. 2016 Mar; 41(3):239-40.
-
Zhu HJ, Hess S, Rubello D, Goris ML, Alavi A. The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism. Nucl Med Commun. 2016 Mar; 37(3):322-8.
-
Yared JA, Hardy N, Singh Z, Hajj S, Badros AZ, Kocoglu M, Yanovich S, Sausville EA, Ujjani C, Ruehle K, Goecke C, Landau M, Rapoport AP. Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation. Bone Marrow Transplant. 2016 06; 51(6):850-2.
-
Lyons K, Seghers V, Sorensen JI, Zhang W, Paldino MJ, Krishnamurthy R, Rohren EM. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Nov; 205(5):1094-101.
-
Stehouwer JS, Bourke CH, Owens MJ, Voll RJ, Kilts CD, Goodman MM. Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors. Bioorg Med Chem Lett. 2015 Nov 15; 25(22):5111-4.
-
Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology. 2015; 89(6):305-10.
-
Lyons K, Seghers V, Williams JL, Sorensen JI, Paldino MJ, Krishnamurthy R, Rohren EM. Qualitative FDG PET Image Assessment Using Automated Three-Segment MR Attenuation Correction Versus CT Attenuation Correction in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Sep; 205(3):652-8.
-
Ganesh Y, Yadala V, Reddy IS, De Padua M. A rare case of fever of unknown origin: subcutaneous panniculitis-like T-cell lymphoma (SPTCL). BMJ Case Rep. 2015 Aug 19; 2015.
-
Bonasso P, Turner J, Khan F, Nakayama D, Richmond B. Moans, Bones, Groans, and a Thyroid Mass. Am Surg. 2015 Aug; 81(8):319-21.
-
Stehouwer JS, Birnbaum MS, Voll RJ, Owens MJ, Plott SJ, Bourke CH, Wassef MA, Kilts CD, Goodman MM. Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor. Bioorg Med Chem. 2015 Aug 01; 23(15):4286-4302.
-
Zaheer A, Wadhwa V, Oh J, Fishman EK. Pearls and pitfalls of imaging metastatic disease from pancreatic adenocarcinoma: a systematic review. Clin Imaging. 2015 Sep-Oct; 39(5):750-8.
-
Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH. Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management. Can Assoc Radiol J. 2015 May; 66(2):130-9.
-
Bhutani M, Landgren O, Usmani SZ. Multiple myeloma: is it time for biomarker-driven therapy? Am Soc Clin Oncol Educ Book. 2015; e493-503.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|